X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Multiple Sclerosis Journal

期刊標題檢索 MULT SCLER J 最新評論: Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Research Focu... (2023-10-24)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Multiple Sclerosis Journal]您好,您是該頁面的第 14780 位訪客。

期刊簡介
期刊名稱Multiple Sclerosis Journal Multiple Sclerosis Journal

According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is MULT SCLER)
LetPub Score
7.5
50 ratings
Rate

Reputation
8.7

Influence
6.2

Speed
9.6

期刊簡稱MULT SCLER J
ISSN1352-4585
E-ISSN1477-0970
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.901.9011.393
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Neurology
Q116 / 192
Category: Neuroscience
Subcategory: Neurology (clinical)
Q135 / 400

自引率 (2023-2024)10.40%自引率趨勢
掲載範囲
Multiple Sclerosis Journal is a peer-reviewed international journal that focuses on all aspects of multiple sclerosis, neuromyelitis optica and other related autoimmune diseases of the central nervous system.

The journal for your research in the following areas:

* __Biologic basis:__ pathology, myelin biology, pathophysiology of the blood/brain barrier, axo-glial pathobiology, remyelination, virology and microbiome, immunology, proteomics
* __Epidemology and genetics:__ genetics epigenetics, epidemiology
* __Clinical and Neuroimaging:__ clinical neurology, biomarkers, neuroimaging and clinical outcome measures
* __Therapeutics and rehabilitation:__ therapeutics, rehabilitation, psychology, neuroplasticity, neuroprotection, and systematic management

Print ISSN: 1352-4585
官方網站https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820
在線稿件提交https://uk.sagepub.com/en-gb/asi/multiple-sclerosis-journal/journal201820#submission-guidelines
開放訪問No
出版商SAGE Publications Ltd
主題領域CLINICAL NEUROLOGY
出版國/地區ENGLAND
發行頻率
創刊年0
每年文章數163每年文章數趨勢
黃金OA百分比35.11%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CLINICAL NEUROLOGYSCIEQ138/277
NEUROSCIENCESSCIEQ157/310
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1352-4585%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Multiple Sclerosis Journal】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Molecular AutismH-index: 44

    CiteScore: 12.10
    Neural Regeneration ResearchH-index: 24

    CiteScore: 8.00
    Cognitive ComputationH-index: 36

    CiteScore: 9.30
    Frontiers in Aging NeuroscienceH-index: 55

    CiteScore: 6.30
    Translational Stroke ResearchH-index: 39

    CiteScore: 13.80
    Frontiers in NeurologyH-index: 49

    CiteScore: 4.90
    Frontiers in Behavioral NeuroscienceH-index: 58

    CiteScore: 4.70
    Brain and BehaviorH-index: 30

    CiteScore: 5.30
    Frontiers in NeuroinformaticsH-index: 50

    CiteScore: 4.80
    Frontiers in Computational NeuroscienceH-index: 44

    CiteScore: 5.30
    學科內最受檢索的期刊 頁面查看次數
    Computational Intelligence and Neuroscience232662
    Frontiers in Neurology150114
    Frontiers in Aging Neuroscience109378
    Cognitive Computation99220
    Neural Regeneration Research95664
    Brain and Behavior59096
    Translational Stroke Research46688
    Frontiers in Computational Neuroscience45299
    Frontiers in Behavioral Neuroscience39213
    Frontiers in Neuroinformatics32491
  •  

    Multiple Sclerosis Journal Multiple Sclerosis Journal
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Multiple Sclerosis Journal] 的評論撰寫評論
作者: Jeff Masefield


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-24 10:15:16 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 50.0
Research Focus: Clinical Diagnosis and Treatment; 
Experience Sharing on NMOSD: MS and NMOSD are relatively good journals in this small specialized field. I submitted a review article, and the reviewers were very professional, providing many specific revision suggestions. I made 2 revisions. The review speed was also acceptable.
Submit (12-jul-2023)
Major revision (04-aug-2023)
Re-submit (21-aug-2023)
Minor revision (12-sep-2023)
Re-submit (18-sep-2023)
Accept (20-oct-2023
(0) 讚! | Jeff Masefield

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 14:03:41 評論於
Select the issues to be discussed in depth; discuss the selected issues from multiple perspectives in a certain hierarchy, with reasoning based on facts, and the problems should be clearly and thoroughly explained
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:53:01 評論於
It is generally believed to be this way
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:31:06 評論於
What does it mean to have a deep discussion / How can we deepen the discussion?
(0) 讚! | Darlene Pepys

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 12:25:32 評論於
Is it necessary to include an overview of the article in the first paragraph of a discussion?
(0) 讚! | 魂魄彦露

作者: 珉林水芸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-25 14:48:41 評論於
Direct rejection without clear reasons, suggest considering online platforms
(0) 讚! | 珉林水芸

作者: sophia001


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2018-10-25 09:20:17 評論於
Directly rejected, the reason is unknown, it is recommended to switch to online
(0) 讚! | sophia001

作者: lin


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-06-27 14:34:49 評論於
Very professional!I did not expect to increase points!
(0) 讚! | lin

作者: 灵松小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-27 08:48:41 評論於
Very professional! Didn't expect to get a higher grade!
(0) 讚! | 灵松小姐姐

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 11:32:11 評論於
Stuck in this bottleneck, it's not easy to make further progress, but with a score of over 4 points, it can be considered satisfactory
(0) 讚! | 凌霄高洁

作者: 金顶蒙雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-09-02 12:06:55 評論於
Review speed: 6.0 | Submission hit rate: 25.0
Experience sharing: illogical, unclear expression, directly rejected
(0) 讚! | 金顶蒙雨

作者: Anonymous


領域: 医药科学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2016-09-02 11:11:39 評論於
The logic is unknown, the expression is unclear, and the second is rejected.
(0) 讚! | Anonymous

作者: 宗室笑卉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-04-05 15:43:55 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 25.0
Experience Sharing: Submitted two case studies, both were rejected immediately, reason being insufficient depth in content
(0) 讚! | 宗室笑卉

作者: Hayden Lewis


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-16 10:36:41 評論於
Review speed: 1.0 Experience sharing: Submitted a case study, rejected after 3 weeks, no review comments, citing too many submissions
(0) 讚! | Hayden Lewis

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-03-10 14:45:56 評論於
The journal focuses on the aetiology and pathogenesis of demyelinating and inflammatory diseases of the central nervous system and on the application of such studies to scientifically based therapy. The following research areas are of particular interest to the journal: Clinical neurology Myelin chemistry Neuroimaging Pathobiology of the blood/brain barrier Glial pathobiology/myelin repair Pathology Epidemiology Therapeutics Genetics Immunology Virology Psychology Rehabilitation
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-05-04 11:17:25 評論於
A very professional magazine, the editors and reviewers are professionals engaged in multiple sclerosis research, which is relatively niche domestically. It is easier to publish if it is a long-term study in this field. It does not require too much innovation, but it demands a complete experimental design and rich data
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-06-29 15:57:13 評論於
Bullish, will it rise again next year?
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Multiple Sclerosis Journal] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*